In order to implement those criteria, weight of evidence should be applied considering in particular the approach provided for in Regulation (EU) No 528/2012 and in Regulation (EC) No 1272/2008 of the European Parliament and Council [Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).] on the weight of evidence. Previous experience with the application of the Guidance documenton standardised test guidelines for evaluating chemicals for endocrine disruption of OECD [OECD Series on Testing and Assessment No 150.] should also beconsidered. In addition, the implementation of the criteria should be based on all relevant scientific evidence, including studies submitted in accordance with the current regulatory data requirements of Regulation (EU) No 528/2012. These studies are mostly based on international agreed study protocols.
Recital 3, Regulation (EU) 2017/2100
In forcesince 4 Sep 2017
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 Decembe…Law
Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 Decembe…Law
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…Law
- celex=31967L0548
- celex=31999L0045
- num:eu=1967/548
- num:eu=1999/45